Abstracts tagged "Chronic pain"

Abstract Number: 975 • 2014 ACR/ARHP Annual Meeting
Chronic Pain Predicts Reduced Physical Activity in a Large Population Cohort Study
Kathryn Remmes Martin, Marcus Beasley, Gary J. Macfarlane and Daniel Whibley, Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom
Background/Purpose: Chronic musculoskeletal pain (CP) is associated with reduced levels of physical activity (PA), however few studies have examined the prospective nature of CP on…
Abstract Number: 401 • 2014 ACR/ARHP Annual Meeting
Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
Jowairiyya Ahmad¹, Helena Blumen², Claudene George³, Asha Shrestha⁴ and Clement Tagoe⁵, ¹Geriatrics, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ²Geriatrics, Albert Einstein College of Medicine, Bronx, NY, ³Geriatrics, Albert Einstein College of Medicine/Montefiore Medical centre, Bronx, NY, ⁴Rheumatology, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ⁵Rheumatology, Albert Einsetin College of Medicine/Montefiore Medical Centre, Bronx, NY
Background/Purpose Autoimmune thyroiditis has been linked independently with fibromyalgia and chronic widespread pain. We studied how the presence of autoimmune thyroiditis affects the clinical presentation…
Abstract Number: 266 • 2014 ACR/ARHP Annual Meeting
An Examination of the Interaction of Opioid Use, Pain, and Depression
Jenna Goesling¹, Matthew Henry², Stephanie Moser³, Paul Hilliard⁴, Afton L. Hassett¹ and Chad Brummett⁴, ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI, ³Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, ⁴University of Michigan Medical School, Ann Arbor, MI
Background/Purpose In the past two decades there has been an increase in the use of opioids to treat chronic pain. Despite this trend, there is…
Abstract Number: 260 • 2014 ACR/ARHP Annual Meeting
Validation of the Dutch-Flemish Promis Physical Functioning Item Bank in Patients with Chronic Pain
Martine Crins¹, Caroline Terwee², Niels Smits³, Anton de Vries³, Henrica de Vet², Joost Dekker⁴, Rene Westhovens⁵, David Cella⁶, Karon Cook⁷, Dennis Revicki⁸, Jaap van Leeuwen⁹, Maarten Boers² and Leo D. Roorda¹⁰, ¹Amsterdam Rehabilitation Research Center | Reade, Amsterdam, Netherlands, ²Dep of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, ³VU University Medical Center EMGO Institute for Health and Care Research, Department of Epidemiology and Biostatistics, Amsterdam, Netherlands, ⁴Rehabilitation Medicine, VU University Medical Center, Amsterdam, Netherlands, ⁵University of Leuven, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration; Rheumatology, University Hospital Leuven, Leuven, Belgium, ⁶Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷Center for Patient-Centered Outcomes - Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸Outcomes Research, United BioSource Corporation, Bethesda, MD, ⁹CEO Leones Group BV, Amsterdam, Netherlands, ¹⁰Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands
Background/Purpose: In the assessment of chronic pain patients it is important to measure physical functioning. The National Institutes of Health’s Patient-Reported Outcomes Measurement Information System…
Abstract Number: 243 • 2014 ACR/ARHP Annual Meeting
Safety of Solumatrix Diclofenac in Adults with Osteoarthritis: Results of a 12-Month, Phase 3 Study
Roy Altman¹, Allan Gibofsky², Marc C. Hochberg³, Byron Cryer⁴, Alan J. Kivitz⁵, Vibeke Strand⁶, Olaolu Imasogie⁷ and Clarence Young⁸, ¹University of California–Los Angeles, David Geffen School of Medicine, Los Angeles, CA, ²Medicine and Public Health, Hospital for Special Surgery, New York, NY, ³Division of Rheumatology & Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, ⁴University of Texas Southwestern Medical Center, Dallas, TX, ⁵Altoona Center for Clinical Research, Duncansville, PA, ⁶Stanford University, Palo Alto, CA, ⁷Iroko Pharmaceuticals LLC, Philadelphia, PA, ⁸150 Rouse Boulevard, Iroko Pharmaceuticals, LLC, Phila, PA
Background/Purpose: Osteoarthritis (OA) is a frequent cause of disability in adults. NSAIDs such as diclofenac are often prescribed to treat OA pain. However, NSAIDs…
Abstract Number: 1816 • 2013 ACR/ARHP Annual Meeting
Exercise Therapy Reduces Pain Sensitivity In Patients With Knee Osteoarthritis: A Randomized Controlled Trial
Marius Henriksen¹, Louise Klokker², Thomas Graven-Nielsen³, Cecilie Bartholdy², Tanja Schjoedt Joergensen⁴, Elisabeth Bandak¹, Bente Danneskiold-Samsøe⁵, Robin Christensen⁶ and Henning Bliddal¹, ¹Department of Rheumatology, The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen F, Denmark, ²The Parker Institute, Copenhagen, Denmark, ³Center for Sensori-Motor Interaction, Aalborg University, Aalborg, Denmark, ⁴The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen F, Denmark, ⁵Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, ⁶Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark
Background/Purpose: Exercise has beneficial effects on pain in patients with knee osteoarthritis (OA), yet the underlying analgesic mechanisms are ambiguous. A deeper understanding of the…
Abstract Number: 1097 • 2013 ACR/ARHP Annual Meeting
A Potential Use Of Neurotropin^TM, a Novel Neuro-Modulating Medication, For The Treatment Of Chronic Pain and Fibromyalgia
Kenji Miki^1,2,3, Ryota Hashimoto^4,5,6, Kenrin Shi^2,7,8 and Masao Yukioka⁸, ¹Department of Orthopaedic Surgery, Amagasaki Central Hospital, Amagasaki, Japan, ²Center for Pain Management, Osaka University Hospital, Suita, Japan, ³Dept. of Rheumatology, Yukioka Hospital, Osaka, Japan, ⁴Dept of Rheumatology, Yukioka Hospital, Osaka, Japan, ⁵Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan, ⁶Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan, ⁷Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan, ⁸Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan
Background/Purpose: To date, no established treatment for chronic pain including fibromyalgia has been specified in Japan. Neurotropin, a non-protein extract isolated from the inflamed cutaneous…
Abstract Number: 1104 • 2013 ACR/ARHP Annual Meeting
Quality Of Life and Burden Of Ehlers-Danlos Syndrome (EDS) Type III
Marion Geoffroy¹, Christelle Guillaume¹, Amélie Servettaz¹, Violaine Laurant-Noel¹, Christine Serratrice Sr.², Jacques Serratrice³, Boris Bienvenu⁴ and Roland Jaussaud⁵, ¹Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré. CHU de Reims, Reims, France, ²internal medicine, Foundation Hopital Saint Joseph, Marseille, France, ³Hôpital de la Timone, Marseille, France, ⁴Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, ⁵Médecine interne, maladies infectieuses, immunologie clinique, CHU de Reims, REIMS, France
Background/Purpose: The Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders. Hypermobility type EDS is the most common type…
Abstract Number: 2848 • 2013 ACR/ARHP Annual Meeting
A Randomised Controlled Trial (RCT) of Telephone Delivered Cognitive Behaviour Therapy (tCBT) and Exercise In The Management Of Chronic Widespread Pain (CWP): Identifying Long-Term Outcome and Who Benefits From Which Treatment
Gary J. Macfarlane¹, Marcus Beasley¹, Philip Keeley², Karina Lovell², Philip Hannaford³, Deborah PM Symmons⁴, Steve Woby⁵, Gordon J. Prescott⁶ and The MUSICIAN study team⁷, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²School of Nursing, Midwifery and Health Visiting, University of Manchester, Manchester, United Kingdom, ³Centre for Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom, ⁴Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, ⁵Pennine Acute Hospital NHS Trust, Manchester, United Kingdom, ⁶Statistics Group, University of Aberdeen, Aberdeen, United Kingdom, ⁷Universities of Manchester and Aberdeen, Manchester and Aberdeen, United Kingdom
Background/Purpose: CWP is challenging for rheumatologists to manage and results from long-term epidemiological studies demonstrate that improvement in symptoms is uncommon. Recent reviews have, however, suggested…
Abstract Number: 2857 • 2013 ACR/ARHP Annual Meeting
The Role Of FAM173b As a Newly Identified Regulator Of Chronic Pain
Hanneke Willemen¹, Annemiek Kavelaars², Rafael González Cano^1,3, Cobi Heijnen² and Niels Eijkelkamp⁴, ¹NIDOD, UMC Utrecht, Utrecht, Netherlands, ²MD Anderson Cancer Center, Houston, TX, ³Department of pharmacology, University of Granada, Granada, Spain, ⁴Laboratory of Neuroimmunology and Developmental Origins of Disease (NIDOD), UMC Utrecht, Utrecht, Netherlands
Background/Purpose: Chronic pain is a major debilitating problem in many inflammatory diseases including rheumatoid arthritis and osteoarthritis. Pain is an important problem during active disease…
Abstract Number: 2022 • 2012 ACR/ARHP Annual Meeting
Individual Disease Burden in Children and Adolescents with Chronic Musculoskeletal Pain – Multilevel-Analysis of a Nationwide Prospective Longitudinal Observation Study
Kerstin Gerhold¹, Rebecca Muckelbauer², Jacqueline Müller-Nordhorn², Angelika Thon³, Thomas Müller⁴, Gerd Ganser⁵, Martina Niewerth⁶ and Kirsten Minden⁷, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leipniz Institute, Berlin, Germany, ²Berlin School of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany, ³Kinderklinik der Medizinischen Hochschule Hannover, Hannover, Germany, ⁴Universitätsklinikum Halle (Saale), Halle (Saale), Germany, ⁵Pediatric Rheumatology, Sankt Josef Stift, Sendenhorst, Germany, ⁶Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ⁷Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany
Background/Purpose: Chronic musculoskeletal pain was described to be a frequent complaint in children and adolescents with assumed relevant impairment of health-related quality of life (HRQoL)…
Abstract Number: 803 • 2012 ACR/ARHP Annual Meeting
Frontal Brain Connectivity to the Default Mode Network Is Associated with Subjective Fatigue Irrespective of Pain and Depression
Johnson P. Hampson¹, Daniel J. Clauw², Jieun Kim³, Vitaly Napadow⁴ and Richard E. Harris¹, ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, ³Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, ⁴Radiology, Martinos Center for Biomedical Imaging, Charlestown, MA
Background/Purpose: Chronic pain patients report increased levels of fatigue; however, very little is known about the underlying mechanisms of this symptom. Previous work by our…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].